Open AccessCLL: Phase III Studies Confirm Added Rituximab Better than Chemo Alone
Author(s) -
Peter Goodwin
Publication year - 2009
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000345893.78014.42
Subject(s) - rituximab , fludarabine , medicine , cyclophosphamide , regimen , neutropenia , toxicity , progression free survival , chronic lymphocytic leukemia , gastroenterology , clinical endpoint , chemotherapy , oncology , surgery , leukemia , clinical trial , lymphoma